Chan Henry Lee Bei Gene, Ltd. (BGNE) insider trading activity

BGNE Quotes by TradingView

Chan Henry Lee is SVP, General Counsel of BeiGene, Ltd.. Currently has a direct ownership of 0 shares of BGNE, which is worth approximately $0. The most recent transaction as insider was on Nov 12, 2025, when has been sold 996 shares (American Depositary Shares) at a price of $349.38 per share, resulting in proceeds of $347,982. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Chan Henry Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 12 2025
SELL
Open market or private sale
$347,982 $349.38 p/Share
996 Reduced 100.0%
0 American Depositary Sh...
Nov 12 2025
BUY
Exercise of conversion of derivative security
$188,184 $188.94 p/Share
996 Added 50.0%
996 American Depositary Sh...
Oct 08 2025
SELL
Open market or private sale
$3,732,609 $349.79 p/Share
10,671 Reduced 100.0%
0 American Depositary Sh...
Oct 08 2025
BUY
Exercise of conversion of derivative security
$1,806,077 $188.94 p/Share
9,559 Added 50.0%
9,559 American Depositary Sh...
Sep 10 2025
SELL
Open market or private sale
$3,263,256 $326.13 p/Share
10,006 Reduced 100.0%
0 American Depositary Sh...
Sep 10 2025
BUY
Exercise of conversion of derivative security
$1,680,432 $188.94 p/Share
8,894 Added 50.0%
8,894 American Depositary Sh...
Aug 13 2025
SELL
Open market or private sale
$3,308,305 $300.4 p/Share
11,013 Reduced 100.0%
0 American Depositary Sh...
Aug 13 2025
BUY
Exercise of conversion of derivative security
$1,454,652 $176.75 p/Share
8,230 Added 50.0%
8,230 American Depositary Sh...
Jul 30 2025
SELL
Open market or private sale
$280,232 $304.6 p/Share
920 Reduced 100.0%
0 American Depositary Sh...
Jun 16 2025
SELL
Open market or private sale
$112,463 $266.5 p/Share
422 Reduced 100.0%
0 American Depositary Sh...
Jun 10 2025
BUY
Grant, award, or other acquisition
-
46,878 Added 14.17%
283,920 Ordinary Shares
Jun 06 2025
SELL
Open market or private sale
$179,403 $256.29 p/Share
700 Reduced 100.0%
0 American Depositary Sh...
Mar 05 2025
BUY
Grant, award, or other acquisition
-
40,209 Added 14.04%
246,142 Ordinary Shares
Feb 27 2025
SELL
Open market or private sale
$331,375 $275.0 p/Share
1,205 Reduced 100.0%
0 American Depositary Sh...
Feb 21 2025
SELL
Open market or private sale
$310,813 $258.58 p/Share
1,202 Reduced 100.0%
0 American Depositary Sh...
Sep 30 2024
SELL
Open market or private sale
$284,994 $237.1 p/Share
1,202 Reduced 100.0%
0 American Depositary Sh...
Jul 30 2024
SELL
Open market or private sale
$133,915 $160.57 p/Share
834 Reduced 100.0%
0 American Depositary Sh...
Jun 17 2024
SELL
Open market or private sale
$69,893 $159.21 p/Share
439 Reduced 100.0%
0 American Depositary Sh...
Jun 05 2024
BUY
Grant, award, or other acquisition
-
98,085 Added 26.69%
269,399 Ordinary Shares
Jul 31 2023
SELL
Open market or private sale
$171,061 $216.26 p/Share
791 Reduced 100.0%
0 American Depositary Sh...
Jun 15 2023
BUY
Grant, award, or other acquisition
-
65,585 Added 26.53%
181,597 Ordinary Shares
CHL

Chan Henry Lee

SVP, General Counsel
Camana Bay, Grand Cayman, E9

Track Institutional and Insider Activities on BGNE

Follow BeiGene, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BGNE shares.

Notify only if

Insider Trading

Get notified when an Bei Gene, Ltd. insider buys or sells BGNE shares.

Notify only if

News

Receive news related to BeiGene, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BGNE